A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea

被引:3
|
作者
Seo, Ji-Hye [1 ]
Kim, Ock-Joo [1 ]
Yoo, Sang-Ho [2 ]
Choi, Eun Kyung [3 ]
Park, Ji-Eun [4 ]
机构
[1] Seoul Natl Univ, Dept Hist Med & Med Humanities, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Hanyang Univ, Dept Med Human & Eth, Coll Med, Seoul, South Korea
[3] Korea Natl Inst Bioeth Policy, Seoul, South Korea
[4] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea
关键词
phase I clinical trials; healthy volunteers; informed consent; research ethics;
D O I
10.1177/15562646211034275
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The phase I trial is the first step in administering a drug to humans, but it has no therapeutic purpose. Under the absence of therapeutic purpose, healthy volunteers demonstrated different motivations, unlike the actual patients participating in trials. There were many reported motivations, such as financial motivation, contributing to the health science, accessing ancillary health care benefits, scientific interest or interest in the goals of the study, meeting people, and general curiosity. The aim of this study was to identify the motivation and characteristics of healthy volunteers participating in phase I trials in the Republic of Korea. We gave surveys to 121 healthy volunteers to study their demographic characteristics and the reasons of participation. We identified whether the decision to participate in the research was influenced by demographic factors and whether the perception and attitudes toward the research were influenced by the characteristics of the healthy volunteers. After completion of the first survey, 12 healthy volunteers who had participated in a phase I clinical trial were selected to answer the second interview. According to our survey, most healthy volunteers were unmarried men and economically dependent. Most of them participated in the study because of financial reward. The most important factor to measure financial reward was the research period. Also, 43% of the volunteers were university students, 42% answered "university graduation" and 55% were residing in family-owned houses. Many healthy volunteers were found to be living in family homes and to have a student status or lack of economic independence. Results of the survey showed that 64% of respondents indicated having more than one clinical trial participation. In-depth interviews showed that healthy volunteers had diverse motivation to participate in research and that healthy volunteer perceive the clinical trial positively. The main motivation for healthy volunteers' participation in research was "financial reward." Healthy volunteers also considered research schedules, processes, and safety, and had a positive perception of clinical trials, but they thought that the public has a negative perception.
引用
收藏
页码:193 / 212
页数:20
相关论文
共 50 条
  • [11] A National Registry for Healthy Volunteers in Phase 1 Clinical Trials
    Resnik, David B.
    Koski, Greg
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (12): : 1236 - 1237
  • [12] Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials
    Fisher, Jill A.
    SCIENCE TECHNOLOGY & HUMAN VALUES, 2015, 40 (02) : 199 - 226
  • [13] A phase I study of monohydroxyethylrutoside in healthy volunteers
    Anja M. Willems
    Anne M. Bruynzeel
    Marc A. Kedde
    Cees J. van Groeningen
    Aalt Bast
    Wim J. van der Vijgh
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 678 - 684
  • [14] A phase I study of monohydroxyethylrutoside in healthy volunteers
    Willems, AM
    Bruynzeel, AM
    Kedde, MA
    van Groeningen, CJ
    Bast, A
    van der Vijgh, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 678 - 684
  • [15] MOTIVES AND PERCEPTION OF HEALTHY-VOLUNTEERS WHO PARTICIPATE IN EXPERIMENTS
    VANGELDEREN, CEM
    SAVELKOUL, TJF
    VANDOKKUM, W
    MEULENBELT, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (01) : 15 - 21
  • [16] SENSATION SEEKING AMONGST HEALTHY-VOLUNTEERS PARTICIPATING IN PHASE-I CLINICAL-TRIALS
    FARRE, M
    LAMAS, X
    CAMI, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) : 405 - 409
  • [17] Pharmacokinetics of panomifene in healthy volunteers at phase I/a study
    ErdelyiToth, V
    Gyergyay, F
    Szamel, I
    Pap, E
    Kralovanszky, J
    Bojti, E
    Csorgo, M
    Drabant, S
    Klebovich, I
    ANTI-CANCER DRUGS, 1997, 8 (06) : 603 - 609
  • [18] PHASE I CLINICAL STUDY OF VANCOMYCIN HYDROCHLORIDE INHALATION POWDER (AEROVANC) IN HEALTHY VOLUNTEERS
    Jouhikainen, T.
    Lord, J.
    Hofmann, T.
    Waterer, G.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 342 - 343
  • [19] Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time (vol 16, e0256994, 2021)
    Kalbaugh, C. A.
    Kalbaugh, J. M.
    McManus, L.
    Fisher, J. A.
    PLOS ONE, 2022, 17 (01):
  • [20] Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials
    Girard, I
    Ferry, S
    Nony, P
    Boissel, JP
    THERAPIE, 1996, 51 (02): : 191 - 192